Related Experiment Videos
Adolescent and parent motivation for change affects psychotherapy outcomes among youth with poorly controlled
Deborah A Ellis1, Heidi Berio, April Idalski Carcone
1Pediatric Prevention Research Center, Old Hutzel Hospital, Detroit, MI 48201, USA. dellis@med.wayne.edu
Objectives:
Investigate effect of baseline motivation for change on treatment fidelity, therapeutic alliance, treatment dose, and treatment outcome in a randomized controlled trial of family therapy for youth with poorly controlled diabetes.
Methods:
Seventy-four adolescents and caregivers completed measures of motivation for change. Measures of fidelity, alliance, dose, and youth health status were collected. Structural equation modeling was used to test the direct and indirect effects of motivation on treatment outcomes.
Results:
Parent motivation was significantly related to alliance and fidelity. Only alliance was significantly related to posttreatment metabolic control. In adolescent models, only motivation was significantly related to alliance. In both models, motivation had a significant indirect effect on metabolic control through alliance.
Conclusions:
Findings demonstrate the importance of parent and youth initial motivational status and treatment alliance to treatment outcome among youth with poorly controlled diabetes. Additional research on treatment techniques that promote motivation for change is needed.
Related Concept Videos
Stress Prevention and Stress Management Techniques VI
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Self-Evaluation: Self-Enhancement and Self-Verification
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Type I Diabetes III: Clinical Manifestations
Type I Diabetes II: Pathophysiology